Skip to Content

Lumigan Side Effects

Generic Name: bimatoprost ophthalmic

Note: This document contains side effect information about bimatoprost ophthalmic. Some of the dosage forms listed on this page may not apply to the brand name Lumigan.

For the Consumer

Applies to bimatoprost ophthalmic: ophthalmic solution

Along with its needed effects, bimatoprost ophthalmic (the active ingredient contained in Lumigan) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking bimatoprost ophthalmic:

Less common
  • Blindness
  • bloody eye
  • blurred or decreased vision
  • change in color vision
  • color changes in the skin around the eyes
  • difficulty seeing at night
  • disturbed color perception
  • double vision
  • dry eyes
  • eye color changes
  • fever or chills
  • halos around lights
  • lack or loss of strength
  • loss of vision
  • night blindness
  • overbright appearance of lights
  • redness, burning, dry, or itching eyes
  • redness, pain, swelling of the eye, eyelid, or inner lining of the eyelid
  • tunnel vision

Some side effects of bimatoprost ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common
  • Body aches or pain
  • cough
  • difficulty with breathing
  • ear congestion
  • headache
  • loss of voice
  • nasal congestion
  • redness of the white part of eyes or inside of the eyelids
  • runny nose
  • sneezing
  • sore throat
  • unusual tiredness or weakness
Less common
  • Darkening of the eyelashes
  • eye discharge or excessive tearing
  • eye strain
  • feeling of having something in the eye
  • increase in hair growth
  • increased sensitivity of the eyes to sunlight

For Healthcare Professionals

Applies to bimatoprost ophthalmic: ophthalmic solution

Ocular

Very common (10% or more): Conjunctival hyperemia, ocular pruritus, growth of eyelashes
Common (1% to 10%): Superficial punctate keratitis, corneal erosion, ocular burning, ocular irritation, allergic conjunctivitis, blepharitis, worsening of visual acuity, asthenopia, conjunctival edema, foreign body sensation, ocular dryness, eye pain, photophobia, tearing, eye discharge, visual disturbance/blurred vision, increased iris pigmentation, eyelash darkening, eyelid erythema, eyelid pruritus
Uncommon (0.1% to 1%): Retinal hemorrhage, uveitis, cystoid macular edema, iritis, blepharospasm, eyelid retraction, periorbital erythema, eyelid edema
Very rare (less than 0.01%): Corneal calcification (in association with the use of phosphate containing eye drops in some patients with significantly damaged corneas)
Frequency not reported: Enophthalmos
Postmarketing reports: Increased lacrimation, skin discoloration (periorbital)[Ref]

Dermatologic

Common (1% to 10%): Pigmentation of periocular skin
Uncommon (0.1% to 1%): Hirsutism
Frequency not reported: Abnormal hair growth
Postmarketing reports: Trichorrhexis, madarosis[Ref]

Respiratory

Frequency not reported: Asthma, asthma exacerbation, COPD exacerbation, dyspnea, upper respiratory tract infections, cold[Ref]

Nervous system

Common (1% to 10%): Headache
Uncommon (0.1% to 1%): Dizziness, vertigo[Ref]

Hepatic

Common (1% to 10%): Abnormal liver function test[Ref]

Other

Uncommon (0.1% to 1%): Asthenia[Ref]

Cardiovascular

Common (1% to 10%): Hypertension[Ref]

Gastrointestinal

Uncommon (0.1% to 1%): Nausea[Ref]

General

The most frequently reported adverse reaction was conjunctival hyperemia.[Ref]

Hypersensitivity

Postmarketing reports: Hypersensitivity[Ref]

Psychiatric

Uncommon (0.1% to 1%): Depression[Ref]

References

1. Cerner Multum, Inc. "Australian Product Information." O 0

2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

3. "Product Information. Lumigan (bimatoprost ophthalmic)" Allergan Inc, Irvine, CA.

Some side effects of Lumigan may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide